Sophia Genetics SA (SOPH) - Total Liabilities
Based on the latest financial reports, Sophia Genetics SA (SOPH) has total liabilities worth $102.77 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SOPH long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Sophia Genetics SA - Total Liabilities Trend (2018–2024)
This chart illustrates how Sophia Genetics SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Sophia Genetics SA.
Sophia Genetics SA Competitors by Total Liabilities
The table below lists competitors of Sophia Genetics SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fiverr International Ltd
NYSE:FVRR
|
USA | $263.48 Million |
|
Channel Well Technology Co Ltd
TWO:3078
|
Taiwan | NT$2.90 Billion |
|
Denny’s Corp
NASDAQ:DENN
|
USA | $535.61 Million |
|
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
|
China | CN¥330.26 Million |
|
DYNAGREEN EN.PR.GR.H YC 1
F:DYN
|
Germany | €13.25 Billion |
|
PI Advanced Materials Co. Ltd
KQ:178920
|
Korea | ₩137.93 Billion |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
USA | $335.00 Million |
|
Jiangsu Daybright Intelligent Electric Co Ltd
SHE:300670
|
China | CN¥1.26 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Sophia Genetics SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SOPH net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sophia Genetics SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sophia Genetics SA (2018–2024)
The table below shows the annual total liabilities of Sophia Genetics SA from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $58.82 Million | +7.50% |
| 2023-12-31 | $54.71 Million | +25.18% |
| 2022-12-31 | $43.71 Million | -2.38% |
| 2021-12-31 | $44.77 Million | +41.66% |
| 2020-12-31 | $31.61 Million | +7.49% |
| 2019-12-31 | $29.40 Million | +34.85% |
| 2018-12-31 | $21.80 Million | -- |
About Sophia Genetics SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutic… Read more